EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity

Christina B Karsten iD, Falk F R Buettner, Samanta Cajic, Inga Nehlmeier, Berit Roshani, Antonina Klippert, Ulrike Sauermann, Nicole Stolte-Leeb, Udo Reichl, Rita Gerardy-Schahn, Erdmann Rapp, Christiane Stahl-Hennig und 1 weitere

PLOS Pathogens · 2024

DOI: 10.1371/journal.ppat.1012190 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Christina B Karsten und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute for the Research on HIV and AIDS-associated Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. Hauptthemen laut MEDLINE: Simian Immunodeficiency Virus, CD4-Positive T-Lymphocytes, Macrophages, Antibodies, Neutralizing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Leibniz Foundation, Open Access Publication Fund of the University of Duisburg-Essen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The human immunodeficiency virus (HIV) envelope protein (Env) mediates viral entry into host cells and is the primary target for the humoral immune response. Env is extensively glycosylated, and these glycans shield underlying epitopes from neutralizing antibodies. The glycosylation of Env is influenced by the type of host cell in which the virus is produced. Thus, HIV is distinctly glycosylated by CD4 + T cells, the major target cells, and macrophages. However, the specific differences in glycosylation between viruses produced in these cell types have not been explored at the molecular level. Moreover, it remains unclear whether the production of HIV in CD4 + T cells or macrophages affects the efficiency of viral spread and resistance to neutralization. To address these questions, we employed the simian immunodeficiency virus (SIV) model. Glycan analysis implied higher relative levels of oligomannose-type N -glycans in SIV from CD4 + T cells (T-SIV) compared to SIV from macrophages (M-SIV), and the complex-type N -glycans profiles seem to differ between the two viruses. Notably, M-SIV demonstrated greater infectivity than T-SIV, even when accounting for Env incorporation, suggesting that host cell-dependent factors influence infectivity. Further, M-SIV was more efficiently disseminated by HIV binding cellular lectins. We also evaluated the influence of cell type-dependent differences on SIV’s vulnerability to carbohydrate binding agents (CBAs) and neutralizing antibodies. T-SIV demonstrated greater susceptibility to mannose-specific CBAs, possibly due to its elevated expression of oligomannose-type N -glycans. In contrast, M-SIV exhibited higher susceptibility to neutralizing sera in comparison to T-SIV. These findings underscore the importance of host cell-dependent attributes of SIV, such as glycosylation, in shaping both infectivity and the potential effectiveness of intervention strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Simian Immunodeficiency VirusCD4-Positive T-LymphocytesMacrophagesAntibodies, NeutralizingSimian Acquired Immunodeficiency SyndromeGlycosylationAnimalsHumansMacaca mulattaPolysaccharides

Substanzen

Antibodies, NeutralizingPolysaccharides

Autor:innen und Institutionen

  • Institute for the Research on HIV and AIDS-associated Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Institute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.
  • Proteomics, Institute of Theoretical Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
  • glyXera GmbH, Magdeburg, Germany.
  • Bioprocess Engineering Group, Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany.
  • Infection Biology Unit, German Primate Center-Leibniz Institute for Primate Research, Göttingen, Germany.

ORCID-Profile: Christina B Karsten, Stefan Pöhlmann

Förderung

  • Deutsche Forschungsgemeinschaft
  • Leibniz Foundation
  • Open Access Publication Fund of the University of Duisburg-Essen
  • Leibniz-Gemeinschaft
  • University of Duisburg-Essen

Zitieren

APA

Karsten, C. B., Buettner, F. F. R., Cajic, S., Nehlmeier, I., Roshani, B., Klippert, A., Sauermann, U., Stolte-Leeb, N., Reichl, U., Gerardy-Schahn, R., Rapp, E., Stahl-Hennig, C., & Pöhlmann, S. (2024). Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012190

Vancouver

Karsten CB, Buettner FFR, Cajic S, Nehlmeier I, Roshani B, Klippert A, et al. Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012190

BibTeX
@article{Karsten2024,
  author = {Karsten, Christina B and Buettner, Falk F R and Cajic, Samanta and Nehlmeier, Inga and Roshani, Berit and Klippert, Antonina and Sauermann, Ulrike and Stolte-Leeb, Nicole and Reichl, Udo and Gerardy-Schahn, Rita and Rapp, Erdmann and Stahl-Hennig, Christiane and Pöhlmann, Stefan},
  title = {Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity},
  journal = {PLOS Pathogens},
  year = {2024},
  doi = {10.1371/journal.ppat.1012190}
}
Kostenlos starten →